As of 2025-07-15, the Intrinsic Value of MYND Life Sciences Inc (MYND.CN) is -0.11 CAD. This MYND.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 CAD, the upside of MYND Life Sciences Inc is -251.11%.
Based on its market price of 0.07 CAD and our intrinsic valuation, MYND Life Sciences Inc (MYND.CN) is overvalued by 251.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.11 - -0.11 | -0.11 | -251.11% |
| DDM - Stable | (0.35) - (2.60) | (1.47) | -2206.9% |
| DDM - Multi | (0.53) - (3.00) | (0.89) | -1374.2% |
| Market Cap (mil) | 3.35 |
| Beta | 0.26 |
| Outstanding shares (mil) | 47.82 |
| Enterprise Value (mil) | 6.35 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.48% |
| Cost of Debt | 5.00% |
| WACC | 5.74% |